Wearable pump allows treatment of worsening HF at home

In patients admitted to the hospital with worsening HF, an early discharge strategy involving treatment at home with subcutaneous furosemide via a pump was linked to more days alive and out of the hospital compared with standard care.
For the SUBCUT HF II trial, presented at Heart Failure 2026, researchers randomly assigned 172 patients with worsening HF (mean age, 71 years; 29% women; mean left ventricular ejection fraction, 36%) admitted to the hospital for IV diuretics for congestion to standard care or an early discharge strategy using subcutaneous furosemide (Lasix ONYU, SQ Innovation)

Building a nephrology workforce with patient navigators

NEW ORLEANS — In this video, Lilia Cervantes, MD, MSCS, describes Navigate-Kidney, a community health worker intervention for Latino patients on dialysis.
At the National Kidney Foundation Spring Clinical Meetings, Cervantes, a Healio | Nephrology News & Issues Editorial Advisory Board Member, delved into how a patient navigation system worked in practice to address social challenges and offer training to explain all stages of chronic kidney disease at their literacy level.
Cervantes says she hopes to develop the community health worker intervention further to be scalable across the

Robotic laser system accurately creates LASIK flaps

WASHINGTON — A robotic laser system was able to accurately create LASIK flaps during a prospective study, according to a researcher at the American Society of Cataract and Refractive Surgery meeting.
Gabriel Quesada, MD, and colleagues conducted a single-site study to evaluate the Ally system (Lensar), a dual-pulsed femtosecond laser system. Quesada presented data from an interim analysis comprising 37 eyes with completed flaps.
{{VIDEO}}
“To have a system guided by OCT and a robotic system to create flaps is something that is going to change results in refractive surgery,” Quesada told Healio.

Wegovy reduces body weight for older adults

Once-weekly injectable semaglutide 2.4 mg was linked to reductions in body weight and improvements in multiple cardiometabolic parameters for older adults with obesity, according to a pooled analysis of the STEP trials.
“Older adults represent, in many countries, the age group with the higher prevalence of obesity and related complications,” Luca Busetto, PhD, professor in nutrition and dietetic sciences at University of Padova in Italy, told Healio. “Nearly half of the cases of obesity occur in older ages. Despite these epidemiological data, older adults represent a minority in the randomized

Orforglipron helps maintain weight loss in obesity

Adults who lost weight with once-weekly injectable semaglutide or tirzepatide were able to maintain more than 70% of their weight loss after switching to once-daily oral orforglipron, according to phase 3 trial data.
As Healio previously reported from the SURMOUNT-5 trial, tirzepatide (Zepbound, Eli Lilly) conferred greater weight loss than injectable semaglutide (Wegovy, Novo Nordisk) at 72 weeks for adults with overweight or obesity. SURMOUNT-5 participants who lost at least 5% of their body weight and had less than 5% weight change in the final 12 weeks of the study were invited to continue

GLP-1 RAs, fewer headaches linked in intracranial hypertension

CHICAGO — Patients with idiopathic intracranial hypertension lost weight and had fewer headaches with GLP-1 receptor agonists, according to an abstract presented at the American Academy of Neurology Annual Meeting.
Idiopathic intracranial hypertension (IIH) is “a serious neurological disorder presented clinically with chronic headaches, papilledema and visual loss,” Samar Shehata, MBBCh, a medical student at Suez Canal University in Egypt, said during her presentation.
IIH also has a strong association with obesity and greater prevalence among young women with obesity, she continued.

VIDEO: New agents to ‘close the gap’ between oral therapies, biologics for psoriasis

DENVER — In this video, Eingun James Song, MD, FAAD, discusses innovations in psoriasis and the differences in efficacy and safety between biologics and oral therapies at the American Academy of Dermatology Annual Meeting.
“Most of our innovation in psoriasis has mostly been in the biologic space where we’re now pushing anywhere from 80% to 90% of patients able to achieve completely clear or almost clear skin. From a biologic standpoint, I think we have it really good, but the oral therapies have not caught up to our biologics,” Song, director of clinical research and co-chief medical officer

Lung cancer surgery survival similar in older, younger patients

Following surgery for stage IA lung cancer, survival and quality of life were similar between patients aged 80 years and older and patients aged younger than 80 years, according to results published in The Lancet Regional Health – Americas.
“Our findings show that when patients are carefully selected based on their overall health, not just their age, they can tolerate surgery well and experience excellent long-term outcomes,” Raja M. Flores, MD, chair of the department of thoracic surgery in the Mount Sinai Health System, said in a press release from Mount Sinai.
Using data from the prospective

Cardiac arrest before ED arrival common in fatal food anaphylaxis

Symptom onset and cardiac arrest in pediatric cases of fatal food anaphylaxis frequently start outside a health care facility, and cases often involve breathing compromise, according to data from two studies.
Both studies were published in Clinical & Experimental Allergy.
“Our research reveals that in many cases, children did not receive enough [epinephrine] adrenaline before cardiac arrest, and some didn’t carry an [epinephrine autoinjector] at all,” Tom Roberts, MBChB, PhD, NIHR academic clinical lecturer in emergency medicine at Bristol Medical School at the University of Bristol, said

Targeted maternal screened needed to prevent rare lymphoma

Targeted maternal screening could substantially reduce the spread of a virus associated with a rare and fatal malignancy that disproportionately affects certain populations of U.S. adults born in other regions.
Less than a quarter of patients with adult T-cell leukemia/lymphoma (ATLL) survive at least 5 years. An evaluation of more than 3,000 U.S. cases in the past 2 decades revealed non-Hispanic Caribbean-born individuals have 32 times greater incidence than those from the U.S. and Canada.
Screening certain women for human T-leukemia virus type 1 (HTLV-1) to prevent transmission from mother to